Short briefs on devices, ingredients, AI and regulation. Every brief links to its source and carries an evidence rating, so you can tell what is proven from what is promised.
Sources last checked 18 Nov 2026.
Established
A regulator decision, human studies or a shipped product.
Emerging
Early studies, pilots or announcements.
Speculative
Lab-stage or marketing-led, with little human evidence.
In India
RegulationEstablishedAug 2026
Ad regulator: sun-care and de-tan ads top summer violations
The Advertising Standards Council of India reviewed 40 summer advertisements from April to June 2026. Twenty-one were modified or withdrawn without contest and 18 were found in violation. Sun protection and tan removal was the largest category, and claims such as de-tanning in 30 seconds had to be withdrawn or changed for lack of data.
Why it matters: Instant-result claims on de-tan and sun-care products are the ones most often failing substantiation in India. Look for stated test evidence, not speed promises.
Drug regulator: no cosmetic may be used as an injection
Business Today reported that in a public notice dated 18 May 2026 India’s Central Drugs Standard Control Organisation stated that products supplied in injectable form are not cosmetics, and that no cosmetic is permitted to be used as an injection by consumers, professionals or aesthetic clinics. It also said cosmetic labels and advertisements must not make misleading claims or claim to treat medical conditions.
Why it matters: Skin boosters and similar injectables offered as “cosmetic” fall outside cosmetics law. Skincare is what is applied to the surface; injections are procedures.
ChemLinked reports that the Bureau of Indian Standards issued IS 19685:2026, a specification for sunscreen cosmetic products, through a Gazette notification of 15 April 2026. It notes that India’s Cosmetics Rules, 2020 previously had no sunscreen-specific provisions on efficacy claims, labelling or standardised testing.
Why it matters: SPF and PA numbers on Indian sunscreens now have a national specification to be measured against, which should make labels easier to compare.
The standard has been issued. We could not confirm whether or when compliance becomes mandatory.
Report: India’s beauty market about $23 billion, a fifth of it online
Redseer’s February 2026 report sizes India’s beauty and personal care market at about USD 23 billion in FY2025 and projects about USD 40 billion by FY2030. It puts e-commerce’s share at about 20% in FY2025, up from about 8% in FY2020, and projects 32–36% by FY2030.
Why it matters: One in five beauty rupees is already spent online, so more skincare is being chosen on a screen without a tester.
A consultancy estimate whose scope includes oral care, wellness and fragrance. The USD 40 billion figure is a 2030 projection, not today’s size.
Nykaa launches a selfie-based skin scan in its app
On 18 November 2025 Nykaa launched Skin Scan, an in-app feature that analyses a selfie for up to 15 parameters, scores each from 1 to 100 and recommends products. Nykaa says the model was trained on more than 70,000 medically graded images.
Why it matters: India’s largest beauty retailer now steers product discovery with a face scan.
The feature has shipped, but the training figure is the company’s claim and we found no independent accuracy data. See the Which? test for how such scores can vary.
A Press Information Bureau backgrounder dated 17 November 2025 says the Government notified the Digital Personal Data Protection Rules, 2025 on 14 November 2025, giving full effect to the 2023 Act with an eighteen-month phased compliance period. Organisations must give a separate, clear consent notice stating the specific purpose, tell people about a breach without delay, and answer access, correction and erasure requests within 90 days. Penalties run up to ₹250 crore.
Why it matters: Any app that takes a selfie for skin analysis must say plainly what the photo is used for and let you withdraw consent and ask for erasure. Expect clearer consent screens.
Indian skin image dataset released for AI research
DermaCon-IN, accepted at NeurIPS 2025, is a dataset of 5,450 clinical images from about 3,000 patients at outpatient clinics in South India, annotated with 245 diagnoses. It was first submitted to arXiv on 6 June 2025.
Why it matters: Most skin-imaging AI was trained mainly on lighter skin. India-sourced data is a precondition for tools that read Indian skin tones fairly.
This is a clinical research dataset, not a cosmetic one, and not a consumer product.
HUL completes its acquisition of 90.5% of Minimalist
Inc42 reported on 22 April 2025 that Hindustan Unilever completed the acquisition of 90.5% of Uprising Science Pvt Ltd, the parent of Minimalist, in an all-cash deal totalling ₹2,706.44 crore. The January 2025 agreement set a pre-money enterprise valuation of ₹2,955 crore.
Why it matters: An ingredient-transparent, online-first skincare brand now sits inside India’s largest consumer goods company, which should widen where it is sold.
The widely quoted ₹2,955 crore figure is the valuation, not the cash paid.
Briefs summarise the linked source and are not endorsements. A technology being new does not mean it works; check the evidence rating. Nothing here is medical advice. Spotted an error? Tell us through Ask The Skinverse.